Clinical Trials Logo

Preterm Birth Complication clinical trials

View clinical trials related to Preterm Birth Complication.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06262308 Not yet recruiting - Clinical trials for Preterm Birth Complication

Emotional Support for Women Experiencing PPROM

Start date: March 2024
Phase: N/A
Study type: Interventional

Preterm Prelabour Rupture of the Membranes is a pregnancy complication affecting 3% of all pregnancies. Outcomes for both the mother and baby are variable including: preterm delivery, fetal infection, cord prolapse, abruption as well as maternal sepsis and even maternal death. The outcomes are not only variable but the stress and uncertainty can be over a protracted period of time. This is a pilot study that aims to provide personalised psychological intervention at the time of PPROM based on Cognitive Behavioural Principles to see whether this improves psychological outcomes for women.

NCT ID: NCT05232994 Not yet recruiting - Preeclampsia Severe Clinical Trials

Metformin and Esomeprazole For Preterm Pre-eclampsia

Start date: March 1, 2023
Phase: Phase 1
Study type: Interventional

A recent randomized controlled trial by Cluver et al included 180 women with preterm pre-eclampsia between 26+0 to 31+6 weeks' gestation undergoing expectant management: 90 were randomised to extended release metformin and 90 to placebo. Investigators found that extended release metformin (3g daily) can prolong gestation in women with preterm pre-eclampsia. Combination metformin and esomeprazole has shown promise in the treatment of preeclampsia as both agents reduce placental and endothelial secretion of soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin, and reduce endothelial dysfunction.